PRICE INDEXES OF MENTAL HEALTH TREATMENT

心理健康治疗的价格指数

• 批准号: 6539153
• 负责人: RICHARD Gabriel FRANK
• 金额: $ 71.96万
• 依托单位: HARVARD MEDICAL SCHOOL
• 依托单位国家: 美国
• 财政年份: 2000
• 资助国家: 美国
• 起止时间: 2000-09-01 至 2005-06-30
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/6539153
• 关键词: Medicare /Medicaid; behavioral /social science research tag; clinical research; depression; health care cost /financing; human data; managed care; mental disorder chemotherapy; mental health services; psychotherapy; schizophrenia

Price indexes are among the most fundamental of economic statistics. They seek to summarize the cost or price of purchasing or producing a particular set of goods and services to attain a certain level of well being. In the health care area price indexes have been conceptualized as the cost of obtaining a certain outcome or quality of care. As such a price index bears directly on how we view the performance of the health economy. The principal goal of this research is to develop price index measures for mental health systems that makes use of administrative data, incorporating learning from clinical research and clinical expertise. Our aim is to measure spending (or the price) of treatments associated with an expected level of outcome. The research builds on a series of pilot studies that examined the feasibility of constructing price indexes for the acute phase treatment of major depression. In the research described here, we propose to extend pilot research to: 1) a broader view of treatment for depression (acute plus continuation phase treatment), 2) treatment of schizophrenia and 3) a wider range of settings such as an HMOs with limited mental health benefits and a state Medicaid program. The long term aim of this work is to develop measures that will help policy makers and advocates better interpret data on mental health spending and enhance the ability to assess the performance of programs serving large populations using administrative data and existing clinical research. We will draw upon three large data sets including a large privately insured population from 428,000 enrollees for eight years, 366,000 HMO and POS enrollees for four years to over 3 million Medicaid enrollees over four years. To assess outcomes we will use clinical literature along with three expert panels of clinician-researchers to rate expected outcomes for specific combinations of consumers and treatments.

价格指数是最基本的经济统计数据之一。他们试图总结购买或生产一套特定的商品和服务以达到一定水平的福利的成本或价格。在卫生保健领域，价格指数被定义为获得某种结果或保健质量的成本。因为这样的价格指数直接关系到我们如何看待卫生经济的表现。本研究的主要目标是利用行政数据，结合临床研究和临床专业知识，为精神卫生系统制定价格指数措施。我们的目的是衡量与预期结果水平相关的治疗支出（或价格）。这项研究建立在一系列试点研究的基础上，这些研究检验了为重度抑郁症急性期治疗构建价格指数的可行性。在这里描述的研究中，我们建议将试点研究扩展到：1)更广泛的抑郁症治疗（急性期加持续期治疗），2)精神分裂症治疗，3)更广泛的环境，如有限精神健康福利的hmo和国家医疗补助计划。这项工作的长期目标是制定措施，帮助政策制定者和倡导者更好地解释心理健康支出的数据，并提高利用行政数据和现有临床研究评估为大量人口服务的项目绩效的能力。我们将利用三个大的数据集，包括一个庞大的私人保险人口，从428,000名8年的参保人，366,000名HMO和POS参保人，到超过300万4年的医疗补助参保人。为了评估结果，我们将使用临床文献和三个临床研究专家小组来评估特定消费者和治疗组合的预期结果。

项目成果

Obtaining utility estimates of the health value of commonly prescribed treatments for asthma and depression.

• DOI: 10.1177/0272989x08315251
• 发表时间: 2008-09
• 期刊: Medical decision making : an international journal of the Society for Medical Decision Making
• 作者: Edelen MO;Burnam MA;Watkins KE;Escarce JJ;Huskamp H;Goldman HH;Rachelefsky G
• 通讯作者: Rachelefsky G

QUALITY-CONSTANT "PRICES" FOR THE ONGOING TREATMENT OF SCHIZOPHRENIA: AN EXPLORATORY STUDY*

精神分裂症持续治疗的质量恒定“价格”：一项探索性研究*

• DOI: 10.1016/j.qref.2004.05.003
• 发表时间: 2004
• 期刊: The Quarterly review of economics and finance : journal of the Midwest Economics Association
• 作者: Frank,RichardG;Berndt,ErnstR;Busch,AlisaB;Lehman,AnthonyF
• 通讯作者: Lehman,AnthonyF